STOCK TITAN

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Legend Biotech (NASDAQ: LEGN) will host an investor conference call on August 9, 2024, at 8:00 am ET to discuss its Q2 2024 results. The company's senior leaders will review the quarterly performance during the webcast. Investors can join the live audio webcast via a provided weblink, and a replay will be accessible in the Investor Relations section of Legend Biotech's website approximately two hours after the call concludes.

Positive
  • None.
Negative
  • None.

SOMERSET, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Friday, August 9, 2024, to review second-quarter 2024 results.

During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s performance for the quarter.

Investors and other interested parties may join the live audio webcast of the call via this weblink.

A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentation section approximately two hours after the call concludes.

ABOUT LEGEND BIOTECH

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.

INVESTOR CONTACT:

Jessie Yeung
Tel: (732) 956-8271
jessie.yeung@legendbiotech.com

PRESS CONTACT:

Mary Ann Ondish
Tel: (914) 552-4625
media@legendbiotech.com


FAQ

What is the date and time for Legend Biotech's Q2 2024 earnings call?

Legend Biotech's Q2 2024 earnings call will be held on August 9, 2024, at 8:00 am ET.

How can investors join Legend Biotech's Q2 2024 earnings call?

Investors can join the live audio webcast of Legend Biotech's Q2 2024 earnings call via a weblink provided by the company.

Will there be a replay available for Legend Biotech's Q2 2024 earnings call?

Yes, a replay of the webcast will be available in the Investor Relations section of Legend Biotech's website roughly two hours after the call concludes.

What will be discussed during Legend Biotech's Q2 2024 earnings call?

Senior leaders of Legend Biotech will provide an overview of the company's performance for the second quarter of 2024.

What is Legend Biotech's stock symbol on NASDAQ?

Legend Biotech's stock symbol on NASDAQ is LEGN.

Legend Biotech Corporation American Depositary Shares

NASDAQ:LEGN

LEGN Rankings

LEGN Latest News

LEGN Stock Data

9.22B
363.82M
1.31%
51.71%
5.5%
Biotechnology
Healthcare
Link
United States of America
Somerset